FDA Import Refusal AEK-2145772-5/30003/1 — Centaur Pharmaceuticals
The FDA refused shipment AEK-2145772-5/30003/1 from Centaur Pharmaceuticals (India) on Sep 25, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 25, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LDY01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 75